drugset / Trial / NCT05567731
Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aimed to compare the gonadotropin-releasing hormone agonist (ultra-short) protocol versus (short and long) protocols on ovarian reserve in women undergoing intracytoplasmic sperm injection
Timeline
- Start
- 2022-10-15
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triptorelin | Other / unclassified | 0.1 mg | Subcutaneous |
| Subject | buserelin | Unknown | 100 mg | — |
| Background | Gonal-f | Protein / enzyme biologic | 150 iu | — |
| Background | Gonal-f | Protein / enzyme biologic | 225 iu | — |
| Background | Gonal-f | Protein / enzyme biologic | 300 iu | — |
| Background | Menogon | Unknown | 150 iu | — |
| Background | Menogon | Unknown | 300 iu | — |
| Background | short GnRHa | Unknown | 10000 iu | — |